Skip to main content
. 2018 Feb 1;38(9):998–1010. doi: 10.1093/asj/sjy008

Table 3.

Incidence and Median Duration of Common Injection-site Adverse Events

Placebo (n = 504) ATX-101 (n = 515)
Patients, % Median, days Patients, % Median, days
Hematoma (bruising) 70.0 9 71.5 9
Pain 31.3 3 69.5 7
Anesthesia (numbness) 5.8 2 66.2 43
Edema 29.2 4 60.4 10
Swelling 15.7 4 33.2 11
Erythema 17.9 2 26.6 3
Induration 2.6 6 23.3 28
Paresthesia 3.8 2 13.8 10
Nodule 2.6 5 13.4 23
Pruritus 6.0 3 12.4 7